(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.68% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.61%.
Baxter International's revenue in 2024 is $14,997,000,000.On average, 7 Wall Street analysts forecast BAX's revenue for 2024 to be $7,767,197,942,192, with the lowest BAX revenue forecast at $7,749,087,657,534, and the highest BAX revenue forecast at $7,786,330,622,772. On average, 6 Wall Street analysts forecast BAX's revenue for 2025 to be $8,027,543,615,244, with the lowest BAX revenue forecast at $7,959,801,212,364, and the highest BAX revenue forecast at $8,080,318,937,697.
In 2026, BAX is forecast to generate $8,281,202,390,414 in revenue, with the lowest revenue forecast at $8,183,325,326,881 and the highest revenue forecast at $8,386,731,607,860.